Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management (Companion Faculty Lecture)
Research To Practice | Oncology Videos
00:00
Role of Checkpoint Inhibitors in First Line
Strosberg discusses limited data on adding immune checkpoint inhibitors to first‑line therapy and ongoing randomized trials.
Play episode from 09:50
Transcript
